Podcasts about maaa

Host Victor Zhao, FSA, CERA sits down with Frank Cheung, FSA, MAAA, CEO and Founder of Accorded, to explore how modeling headaches and operational friction inspired him to launch an actuarial data and analytics infrastructure startup. Frank shares how he identified the core problem, validated it through deep industry conversations, and took the leap into entrepreneurship.

L'economia mondiale è costretta ad affrontare tempi duri, è cominciata la guerra dei dazi...ma cosa sono in realtà? Learn more about your ad choices. Visit megaphone.fm/adchoices

Hosts Pastor Robert Baltodano and Guest Pastor Bill Beckelman Question Timestamps: John, NJ (1:50) - Does God obligate us to tithe first in the midst of dealing with debt? Trisha, PA (7:11) - Should I anoint my door with the oil my family member gave me? Alyssa, ID (12:43) - Can you explain the Trinity? Ivan, HI (15:34) - Why are so many churches not focusing on Revelation? Minerva, email (19:16) - Is Matthew 24 already complete? Christine, NY (23:15) - Why are pastors not calling out the sin in our culture? Michael, Facebook (33:41) - Does Acts 10:42-48 prove that water baptism isn't required for salvation? Maaa, YouTube (36:59) - Is it wrong to ask God “why?” Tim, NJ (39:31) - Is there such a thing as “luck” or “coincidence?” Will God give you anything you ask for? Ed, NJ (45:58) - What is your opinion on using hypnosis? What about in a medical sense? Is it demonic? Meslissa, YouTube (48:53) - I've heard a Christian song that says “God looks at you and wouldn't change a thing,” is this correct? Isn't the job of the Holy Spirit to transform? John, email (50:31) - Where do our spirits go when we die? Is there a good holding place and a bad holding place? Are we judged for this before the final judgement? Ask Your Questions: 888-712-7434 Answers@bbtlive.org

On this episode of the Astonishing Healthcare podcast, we explore the nuances of stop-loss insurance with Capital Rx's Mike Miele, FSA, MAAA (Senior Vice President of Insured Services). With premiums on the rise due to high-cost claims reaching levels actuaries never thought possible, self-insured plan sponsors need new options and better tools to monitor their costs. Mike, who is a healthcare actuary by training, discusses everything from "What is stop-loss?" and who it's for to what's driving high-cost claims to new heights, the rise of a pharmacy-only stop-loss option, and options plan sponsors have to mitigate risk when "it's not a good time to be in a risk-taking business." Mike comments on broader cost drivers, using GLP-1s as an example, preliminary book-of-business trends (2024 vs. 2023), the importance of surveillance on emerging claims, and more! Related News & Content:Sun Life sees stop-loss problems spiking: Will it force employers to buy fully insured coverage? (BenefitsPro)AH031 - Dissecting Pharmacy Cost Drivers and the Value of PMPM, with Kristin Begley, PharmD, and Mike Miele, FSA, MAAACapital Rx Unveils Healthcare's First Unified Pharmacy and Medical Claims Processing PlatformPlease visit Capital Rx Insights for more information, including this episode's transcript!

In2Leadership keynote speaker Dale Porfilio, FCAS, MAAA, is the Chief Insurance Officer for the Insurance Information Institute (Triple-I) and President of the Insurance Research Council (IRC). In these roles, he leads the research and education activities of both organizations, working closely with Triple-I and IRC subject-matter experts to develop data-driven industry insights and analyses. Dale previously worked at Genworth Financial, Kemper, and Allstate for a total of 29 years. Dale is a Fellow of the Casualty Actuarial Society (FCAS) and Member of the American Academy of Actuaries (MAAA). In this episode of In the Know, Chris Hampshire and Dale discuss climate change, legal system abuse, and some of the topics that Dale will be addressing as the keynote speaker at April's In2Leadership conference.   Key Takeaways   Dale grew up knowing that insurance was always a career option. Actuarial sciences allowed Dale to apply his strengths to insurance organizations. The 2025 insurance industry is in a dynamic state. The outstanding response of the insurance industry to climate change. Risk-based pricing is a critical consideration for carriers' actuarial goals. The importance of allowing market competition and less regulatory restrictions. The name “legal system abuse” does matter. Developments in the legal system abuse sphere. The impact of third-party litigation funding on the commercial sector. Strategies for improving the practice of third-party litigation funding. Dale's pragmatic take on the five-year future of the insurance industry. Embracing technology in ways that are helpful to the future of insurance.   Quotes “For me, I always knew that insurance was an option.” “The 2025 insurance industry is in quite a dynamic state.” “Allowing market competition and less regulatory restrictions is helpful overall.” “How can we make the practice of third-party litigation funding as healthy as possible?” “Insurance companies are here to make people whole. We don't always need to have attorneys involved at the level they are today.”  

In this video, we interview Chris Lombardi, FSA, MAAA, CERA Associate Director at WTW, and Jeanne Cho Stokke, FSA, MAAA, about goal setting and people management. They share techniques and tools for actuaries to become effective leaders in the profession. Jeanne's experience as a former Pro LPGA golfer and Chris's background in jiu jitsu highlight how these skills have contributed to their career success.

Hello Listeners!  In this classic episode, we heard from two esteemed actuaries: John Bertko, FSA, MAAA, an independent actuarial consultant serving as the Chief Actuary with Covered California, and Steve Goss, ASA, MAAA, the Chief Actuary at the Social Security Administration discussing the implications of a new U.S. administration on actuarial practice.  This podcast originally published in January 2021, capturing the thoughts and perspectives of our experts during a pivotal time of transition. We hope you enjoy this insightful discussion and find it as relevant today as it was when it first aired.  Sit back, relax and enjoy this Research Insights Classic!

Episode 125 of The Reseller Clickbait Podcast featuring Ken - SSKPromo and Cory - Grams & Pops Vintage. Happy Thanksgiving Everyone! "The Twinsies Podcast." Cory could use a night of uninterrupted sleep. Ken needs to rethink his priorities. If you wait till the last minute, you get everything done in a minute. Idea guys are a Dime a Dozen. STUFF IT!!

What is your brand? How did you get to be there? What was the moment? Whatever point of your career you are in, your brand is yours to define, to model, to sell. Tasso Bountouvas, FSA, CERA hosts Mitch Stephenson, FSA, MAAA to delve into the notion of one's personal brand and its development. Building off of Mitch's recently published article: Defining Your Brand: It's the Little Things, listen as they both share a bit of the experiences that have shaped their perspectives and advice on what it takes to succeed in branding.

The magic of books through my son's curious questions. Every moment spent together is a beautiful chapter in our story. Let's dive into this journey together!

My recollections of years spent engaging in mas celebrations in New York City, I have vivid memories of Eastern Parkway and the vibrant Miami Carnival.

Hello, Listeners! Welcome back to our 75th Anniversary Podcast Series! In Episode 5 – The 2010s: Pandemic and Progress, we are joined by John Robinson, FSA, MAAA, FCA. Tune in to hear John share his career journey and his experiences as the 74th President of the Society of Actuaries (2023-24).

In this episode Roy Ju, FSA, CERA, MAAA, joins host Nick Kocisak, ASA, to discuss how to build credibility early in your career and accelerate your professional growth. Roy shares his experience through his exam journey and highlights some of the key actions and perspectives that have fueled his success. 

In this episode of the Astonishing Healthcare podcast, Justin Venneri sits down with Kristen Begley, PharmD, Chief Commercial Officer, and Michael Miele, FSA, MAAA, Senior Vice President of Insured Services, for a discussion about some of the finer points of pharmacy benefit management (PBM) procurement and pharmacy program cost evaluation, including how misaligned incentives can drive costs higher than they should be for plan sponsors. They delve into the misleading nature of focusing on unit costs and high rebates and advocate for a per member per month (PMPM) model to gain a clearer picture of true costs and hold PBMs accountable.Kristin and Mike suggest ways to update and improve legacy PBM evaluation methods, encouraging stakeholders to more carefully consider everything from the questionnaires leveraged to screen potential PBM partners to the true value of clinical programs for utilization management - such as prior authorization - and the actual number of units used to forecast spending.Related PMPM Content:AH010 - The Power of PMPM: Holding PBMs Accountable for Total Drug Spend, with Kristin Begley, PharmDPMPM - Is It the Best Way to Measure or Track Anything?PBM Procurement: A PMPM Guide for Plans Sponsors eBookVisit Capital Rx Insights for this episode's transcript and additional content!

Host Nick Kocisak, ASA, is joined by Austin Kang, FSA, MAAA, CERA, to discuss the importance of being more than just a "number cruncher" as you fulfill your actuarial duties.  Austin shares his experience working in the health consulting industry and provides lessons learned on how to leverage your actuarial background to gain trust and confidence with your clients and coworkers. 

Greetings Listeners!  It is time for another episode of the Society of Actuaries Research Insights Podcast!  Listen to Joan Barrett, FSA, MAAA and Consulting Actuary at Axene Health Partners, LLC, and Greg Warren, FSA, FCA, MAAA, Partner and Consulting Actuary at Axene Health Partners, LLC talk with Dale Hall, Managing Director of Research at the Research Institute about the SOA Societal Purpose Report “Reimagining Pharmacy Financing.”  This report discusses a value-based reimbursement methodology that increases transparency, encourages competition, aligns stakeholder incentives and mitigates total cost of care (TCOC) increases.   Landing Page:  https://www.soa.org/resources/research-reports/2024/reimagining-pharmacy-financing/   Send us your feedback at:  ResearchInsights@soa.org 

In this podcast episode, Jonas Brobbey hosts Elizabeth Dietrich FSA, CERA, MAAA, who takes us through her career journey from Actuary to CFO and provides actionable tips on navigating and forging a successful career as an Actuary.   

Good afternoon Listeners!  It is time for another episode of the Society of Actuaries Research Insights Podcast!  We have a great Research Insights Podcast Classic to bring to you today. We searched through our archive for a podcast that would be appropriate for this time of year, and we came up with “Climate Related Health Issues” which was first published as a Focus Edition on July 27, 2022.  Hear R. Dale Hall, FSA, CERA, MAAA, CFA, SOA Research Institute Managing Director, discuss climate related health issues, which are especially relevant in this current season of extreme heat.  Enjoy this Research Insights Podcast Classic!   Send us your feedback at ResearchInsights@soa.org

Join host Nick Kocisak, ASA and guest Taylor Pickett, FSA, MAAA for a discussion of the importance of leveraging foundational actuarial principles and communicating effectively when working in innovative areas of the profession. Taylor shares his experience working with accelerated underwriting programs around the industry and provides insights into how he and his team help insurers get comfortable with the assumptions developed for each unique program. 

Greetings Listeners!  We have another great episode of the Get Plugged In Podcast for you this morning.  Hear Host Arthur da Silva and Guest Sherry Chan, FSA, EA, MAAA, Chief Strategy Officer for Atidot and Society of Actuaries Board Member, talk about Sherry's InsurTech and Actuarial career journey.

Join us for another exciting YPAC podcast as host Shawn Stender, FSA, MAAA, discusses unique actuarial career journeys with Lana Marozava, ASA, CERA, and Joe Long, ASA, MAAA. This podcast will shed light on the numerous different paths that young professionals can take on their journey to become an actuary. Whether that means changing careers from a teacher, project manager, or data scientist or just taking the exams at your own pace—this podcast will help young actuaries understand that there is more than one way to be successful in actuarial work.  

What is professionalism?  Is it just following the law?  The code/rules of professional conduct?  Is it more than both of those? Listen to our podcast where YPAC member Patrick Samborsky, ASA, MAAA discusses professionalism with Charly J Pazdor, FSA retired, who has written about professionalism for The Actuary magazine as well as being a course director and facilitator for the FAC. 

In the first of a series to further explore and differentiate the regulatory bodies and rating agencies overseeing the insurance industry, this podcast presents a conversation with Matthew Mosher, MAAA, FCAS, CERA, President and CEO of AM Best Rating Services. Matt presents an overview of the goals of and approaches taken to evaluate insurance companies with a focus on the important considerations for financial reporting actuaries and how they assist the relationship between AM Best and the companies under review.

In this podcast, fast-rising leader in the reinsurance space, Stephen Abrokwah Ph.D, FSA, CERA, MAAA, shares some general knowledge about reinsurance and delves a bit more into his own career journey and experience as a client-facing reinsurance Actuary.

Welcome back Listeners!  We have another great episode of the Society of Actuaries Research Institute Research Insights Podcast!  Hear discussion of the report “Challenges and Opportunities with Rethinking Fairness Metrics for Life Insurance Processes: An Actuarial Perspective” which focuses on issues with respect to fairness in the context of processes involved in developing and managing life insurance, especially risk classification, without offering specific solutions or engaging in legal or political debate. Author and Host:  Lisa A. Schilling, FSA, EA, FCA, MAAA Advisory Panel Guests:  Hezhong (Mark) Ma, FSA, MAAA, Bruce A. Friedland, FSA, MAAA Landing page:  https://www.soa.org/resources/research-reports/2023/fairness-metrics-life-insurance/

We are at the MHSAA - MAA Meetings in Biloxit to kick off the 2024 sports year. Steve Robertson talks Mississippi State Sports, Chris Landry on NFL and college football and more.

Bobby Hall joins the show to discuss his career and being inducted into the MAAA Hall of Fame.

Tom Gladney discusses his baseball career and induction into the MAAA Hall of Fame.

It's day two of the MHSAA - MAAA conference on the Mississippi Gulf Coast. Bobby Hall, Adam Johnson and more on the program. Raphael Esparza on the NFL Playoffs.

For a full transcript of this episode, click here. For a deep dive into the way back backstory here, listen to the show with Dea Belazi, PharmD, MPH. That's episode 293, and it's entitled “Game Theory Gone Wild,” because gone wild is what has happened with pharma manufacturer co-pay assistance programs. Don't forget that the original intent of the first chess move here was by pharma manufacturers to circumvent basically PBM (pharmacy benefit manager) formulary restrictions, because the leverage PBMs have is access and patient out-of-pocket costs—and let's focus on the out-of-pocket costs right now. If a drug is on formulary, patients can get said drug for a lower relative price. Drugs not on formulary are abandoned at the pharmacy counter quite often because patients cannot afford them, and this is by design. This patient abandonment of their prescriptions is what gives the PBM leverage when negotiating with Pharma. If Pharma doesn't play by PBM rules, they get kicked off the formulary; and then patients can no longer afford to get their meds and pharma market share tanks. So, the original intent of co-pay cards was for Pharma to say, “Ha ha, talk to the hand, you PBMs. You can not put us on formulary if you want, but I'm gonna lower the out-of-pocket costs all by meself with me co-pay cards. If you, PBM, force a $300 co-pay or whatever, which is way too high for most patients, I, Pharma, will pay $275 of that (or maybe all $300) a month on the patient's behalf with my co-pay card program. So, patients are now left with a reasonable amount that they should be able to afford, and my pharma drug's market share is unhindered.” I think one thing to keep in mind here as we evaluate the net impact is that not all situations are the same. Let's say there's two main scenarios—and keep both of these in mind during the conversation that follows with Joey Dizenhouse as you consider the impact on plan sponsors and patients vis-à-vis their premiums and also on patients/members in the short term. Scenario #1: Let's say there's one drug out there for a particular condition. One drug. And on some plan, that one drug has a ridiculously expensive out-of-pocket cost, say, $8000 or something like this, whatever their deductible or the max out-of-pocket is for that particular member on that particular plan. And this is $8000 every year if this is a chronic condition, which makes it different than someone hitting their deductible this year because they had a knee replacement or whatever. In this first scenario, we're talking about patients or their kids who in perpetuity need a drug and who effectively just had their salary reduced year over year by $8000 or whatever. If they want the med, they have no other option than this huge out of pocket. That's one situation. Scenario #2: Let's say there's another really expensive drug, but in this scenario, there's a generic equivalent or there's some other brand that costs $70 and works for most patients. So, yeah … now we have patients who get a co-pay card and are thus incented by their low or no out of pocket to get a drug that is effectively a rip-off. So, now the plan is paying something upwards of $8000 instead of $70. And it's not like the patient got a better product. It's upwards of 8000 wasted plan dollars that really don't accrue any better health. And so, this is really where our story begins. A couple of definitions here: Maximizer refers to the entity running a maximizer program. It's a noun. It's a who. Oftentimes the maximizer is the PBM, but not always. Joey talks about two kinds of maximizer programs: One is what Joey calls a spread model, and then there's also the transparent model. We also in the podcast that follows talk about a scheme which is often pitched to plan sponsors that I'm going to call the “the drug's not covered” approach. At the end of the show, we come up with three bits of advice. And here they are, spoiler alert: 1. Buyer beware. If you are a self-insured employer or some other entity who is purchasing these maximizer programs, purchasing due diligence is required. If your vendor makes more money the more a drug costs, yeah, you have misaligned incentives and the chances of you (the plan sponsor) and all of your members getting screwed is on the high side. (Eric Bricker, MD, shows how this could work in this video about the Cigna “transparent” CostVantage offering.) 2. As Lauren Vela said also in episode 406, everybody always thinks that their contracts are amazing. It's everybody else's contracts that suck. You ask a roomful of HR folks if their PBM contracts are above average, and the whole room raises their hands. This ain't Lake Wobegon, folks. Don't kill the messenger. 3. Get on the ground and actually talk to plan members who are taking these drugs or who have kids taking drugs that are covered by these maximizer programs or covered by the “it's not covered” alternative funding programs. I certainly hope no one listening is taking the word of the program sponsor on how satisfied plan members are, especially with all these class action lawsuits afoot. My guest today, as aforementioned, is Joey Dizenhouse, FSA, MAAA. He is an actuary by background. He serves as CEO of SlateRx, which is a pharmacy benefit experience provider, or a PBX, as they call it. He is also head of HealthTrust IHP. Also mentioned in this episode are Dea Belazi, PharmD, MPH; Eric Bricker, MD; Lauren Vela; Andreas Mang; and Kollet Koulianos, MBA. You can learn more at SlateRx.   Joey Dizenhouse, FSA, MAAA, has spent more than 25 years in the healthcare industry, serving in a number of strategic, leadership roles. As president and chief executive officer at SlateRx, Joey is responsible for driving the organization's mission of revolutionizing the pharmacy benefit experience. With a key focus on servant leadership and innovation, he seeks value for SlateRx's clients and their covered lives across the complex pharmacy supply chain. He also provides strategic guidance for partner organization HealthTrust. At HealthTrust, Joey led the Insurance, Human Capital, and Pharmacy (IHP) business segment, managing more than $15 billion in annual drug purchasing. Prior to HealthTrust, Joey spent 15 years at a large professional services consulting firm in a number of health and welfare leadership roles, serving many organizations during his tenure, including several from the Fortune 100. Joey is a frequent public speaker on subject matter related to pharmacy insurance, benefits strategies, and the US healthcare landscape. He is a fellow of the Society of Actuaries, member of the American Academy of Actuaries, and a licensed life and health insurance agent across all 50 states.   06:21 How was the first iteration of maximizers conceived? 10:59 “I'd always encourage you to come back to the underlying incentives.” 11:18 What does maximizer acceleration look like? 12:24 What are the two kinds of maximizers? 12:43 What is the spread model for a maximizer? 13:02 What is the transparent model for a maximizer? 15:26 “Ask the questions: How do you make money? Prove it!” 15:56 EP419 with Andreas Mang. 16:25 How might Pharma be making more money with maximizers? 26:14 What is the “it's not covered” approach? 32:29 “The right kind of program has been properly narrowed.” 33:51 Is there a purpose that some of these programs can serve, issues aside? 35:57 How does a free drug program actually cost money?   You can learn more at SlateRx.   Joey Dizenhouse discusses #pharmacybenefits, #employer #costsavings, and #outofpocket costs on our #healthcarepodcast. #healthcare #podcast #pharma #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Benjamin Jolley, Emily Kagan Trenchard (Encore! EP392), Cora Opsahl (Encore! EP372), Jodilyn Owen, Ge Bai, Andreas Mang, Karen Root (Encore! EP381), Mark Cuban and Ferrin Williams, Dan Mendelson (Encore! EP385), Josh Berlin  

Join us for a captivating episode as YPAC Member Silver Zhou, FSA, MAAA, sits down with special guest Andres (Andy) Montes, ASA, MAAA, MBA. Delving into Andy's one-of-a-kind international career journey, offering valuable insights for those looking to shape their own distinctive career paths. Discover the benefits of working abroad and how to seize those exciting prospects!

Join Young Professional Advisory Council Chair Kiu Yuen, FSA, MAAA as she chats with SOA's Beth Gall, Senior Director, Member and Candidate Engagement. Beth discusses the various ways SOA supports candidates, members, DEI initiatives and volunteerism. 

Robert Eaton, MAAA, FSA, a longstanding Academy volunteer, joins the latest episode of Actuary Voices to discuss the changing landscape of artificial intelligence in actuarial work. Eaton is the author of a recent Contingenciesarticle on this topic.

Host Rong Rong, FSA, CPCU, learns about uncommon actuarial and entrepreneurship experiences with generalist actuary Sam Wehner, ASA, MAAA.

Join Lisa Jiang, FSA, MAAA and Young Professional Advisory Council (YPAC) member as she talks with fellow YPAC member Patrick Samborsky, ASA, MAAA, and colleagues Jing Qian, ASA, MAAA and Joyce Wang, FCAS about their unique experiences working in both consulting and insurance. 

In this episode, Eric sits down with Executive Director of the nonprofit Museum of African American Art in Los Angeles; Keasha Dumas Heath. They discuss her passion for storytelling, affinity for poetry and the interconnectivity of the arts. The history and legacy of the museum, including the founder Dr. Samella Lewis… the role that MAAA has played in the community as a cultural institution and sharing African American art and culture with the public. The various permanent collections in their possession, including an extensive archive and their important restoration work. The current exhibition on show “From the HeArt”, the exciting activities and upcoming events in store. . For more visit: www.ericsperspective.comGuest Bio: Keasha Dumas Heath is Executive Director of the Museum of African American Art in Los Angeles; a small nonprofit museum where she helps guide communications, member engagement, visitor experience, community outreach, and program development. Keasha is also a member of the board of directors for the California Association of Museums, a statewide museum advocacy organization, where she is a Vice President and serves on the Government Relations, Membership, and Executive committees. She is a past participant in the annual Museums Advocacy Day hosted by the American Alliance of Museums in Washington, DC, and her interests include arts education, museum/school collaborations, public/private partnerships in the arts, and issues affecting community arts organizations. Keasha holds an M.A. in English from Howard University, and she is an alumna of the Getty Foundation's Multicultural Internship Program.MAAA was founded in 1976 by noted artist and art historian Dr. Samella Lewis and a group of academic, artistic, business, and community leaders whose goal was to increase public awareness of and support for African American art.About Eric's Perspective: A podcast series on African American art with Eric Hanks — African American art specialist, owner of the renowned M. Hanks Gallery and commissioner on the Los Angeles County Arts Commission; offers his perspective on African American art through in-depth conversations with fellow art enthusiasts where they discuss the past, present & future of African American art.For more on Eric's Perspective, visit www.ericsperspective.com#ERICSPERSPECTIVE #AFRICANAMERICAN #ART SUBSCRIBE: http://bit.ly/2vVJkDn LISTEN ON: Apple Podcasts: https://apple.co/2B6wB3USpotify: https://spoti.fi/3j6QRmWGoogle Podcasts: https://bit.ly/3fNNgrYiHeartRadio: https://ihr.fm/2KtYGXv Pandora: https://pdora.co/38pFWAmConnect with us ONLINE: Visit Eric's Perspective website: https://bit.ly/2ZQ41x1Facebook: https://bit.ly/3jq5fXPInstagram: https://bit.ly/39jFZxGTwitter: https://bit.ly/2OMRx33 www.mhanksgallery.comAbout Eric Hanks: African American art specialist and owner of the renowned M. Hanks Gallery, Eric Hanks is one of the leading representatives of Black artists, promoting and selling their works nationally to individual and museum collections, publishing exhibition catalogues, teaching art appreciation classes, and writing articles and essays appearing in prestigious art books and various other publications. 

Listen to Tim Geddes, FSA, EA, MAAA and Managing Director at Deloitte talk about the Society of Actuaries Research Institute report “What Retirement Plan Features Do Employees Really Want?”  This report provides important observations for employers and other retirement stakeholders as they assess retirement plans.  After listening to the podcast, check out the Choice Simulator Tool on the landing page link below. Podcast:  Report landing page:  https://www.soa.org/resources/research-reports/2023/ret-plan-features-emp-want/

Don't miss our latest Research Insights Podcast straight to you from the Research Institute at the Society of Actuaries!  Listen to Sara Teppema, FSA, MAAA, FCA and Chief Actuary at Wildflower Health and Rebecca Owen, FSA, MAAA and Principal at Oregon Coast Actuarial, discuss social physical and cultural determinants of health and their incorporation into the actuarial data and workstreams. Landing page:  https://www.soa.org/resources/research-reports/2023/soc-phy-cultural-doh/ Report:  chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.soa.org/496f00/globalassets/assets/files/resources/research-report/2023/sdoh_act_data_workstreams.pdf 

Neil Tank has been a committed administrator of aeromodelling in Australia for most of his life. As President of his local club, to President of the MAAA, Neil has been seen as a leader behind the aeromodelling scene. An avid aeromodeller, Neil joins us to share his story from starting out in the hobby to having the top job in Australian aeromodelling.

Listen in on a robust conversation with Harrison Lin, FSA, MAAA, YPAC member and Vice-Chair of the SOA DEI Committee as he discusses exciting new DEI initiatives with Karthik Balaji, FSA, EA and Chair of the Joint Committee on Inclusion, Equity & Diversity. 

Longevity Risk Management was awarded first place in the 2022-23 Speculative Fiction Contest. This An audio version is part of the first place prize package. Here's what literary judge, Dr. Bob Mielke, had to say about the story, "What a great little story! We have here an engaging conflict, some action, punchy dialogue, and plausible world-building. Nice focus! The whole issue of whether one would ever get too old to want to live has a venerable pedigree in the speculative genre..."

YPAC member Elizabeth Alleman, FSA, MAAA discusses the SOA's Catastrophe and Climate Risk research efforts with a few young professionals who dedicate their time to the program: Priya Rohatgi, ASA, Matt Self, ASA, and Aadit Sheth, FSA, ACIA, CERA. 

Young Professional Advisory Council's Silver Zhou, FSA, MAAA, discusses the importance of personal brand and building your reputation with Aree Bly and Jon Forster, ASA, MAAA. Also learn more about the SOA Next Generation Leaders Summit, where Aree will be leading a session on this topic. 

Dave Dillon discussed with Paul Conlin, FSA, MAAA, the recently-published book “Power Failure” by William Cohan, on the 2001-2018 unraveling of General Electric.  One of the business events which led to the near-failure of GE was an under-reserving of Long Term Care reserves by 16 billion dollars, discovered in 2018 just as various other problems were emerging for the company.  There are lessons for actuaries in the series of events which led to the LTC reserve “accident”.

In the United States, individuals needing long-term services and supports (LTSS) access care, utilize services, and pay for their services in various ways. The authors explore how the need for, utilization of and payment for long-term services and supports differ in the U.S. by population cohorts. Their primary focus is disparity by race and ethnicity, but they also consider variations by geography, family structure, age, sex, gender and other socioeconomic factors. Our guest on this podcast is Rebecca Sheppard, FSA, MAAA, from Risk and Regulatory Consulting.  R. Dale Hall, SOA Managing Director of the SOA Research Institute hosts the podcast.

We take a deep dive into the highlights of the SOA Research Institute's new CDC U.S. Population Mortality results with Cynthia MacDonald and Jerry Holman.  R. Dale Hall, FSA, CERA, MAAA, CFA, SOA Managing Director of the SOA Research Institute hosts the podcast. We welcome your questions or comments at researchinsights@soa.org

Listen to SOA Research Institute actuaries Cynthia MacDonald, Rob Montgomery, Achilles Natsis, Lisa Schilling,  David Schraub, Steven Siegel, and Ronora Stryker look ahead to 2023, both personally and professionally, with host, R. Dale Hall, FSA, CERA, MAAA, CFA, SOA Managing Director of the SOA Research Institute. We welcome your questions or comments at researchinsights@soa.org

Listen to SOA Research Institute actuaries Cynthia MacDonald, Rob Montgomery, Achilles Natsis, Lisa Schilling, David Schraub, Steven Siegel, and Ronora Stryker look back on 2022, both personally and professionally, with host, R. Dale Hall, FSA, CERA, MAAA, CFA, SOA Managing Director of the SOA Research Institute. We welcome your questions or comments at researchinsights@soa.org